Ms. Rezvan's Success Story

Chart 1: Weight changes

Ms. R.H., 58 years old, who in Farvardin 1400 (March–April 2021) was diagnosed with type 2 diabetes, joined the Ketonia medical commission on 15 Azar 1401 (December 2022); the patient's history was as follows:

At the commission, her weight was recorded as 55.5 kg, height 148 cm, BMI 25.3, waist 91 cm, and hip 100 cm.

The result of Ketonia's initial commission was announced to the patient as follows:

Our main intervention is lifestyle correction; various aspects of your lifestyle — especially nutrition and sleep — need correcting. Misconceptions will also be corrected; it is best not to resist that.

Your blood sugar is currently at the stage that requires insulin injections. However, since insulin creates a vicious cycle, we prefer to avoid reaching that stage..

We need blood tests to update the lipid and glucose profile and determine the state of the hypothyroidism.

With the explanations given at the Ketonia medical commission, the patient was very interested in joining the Ketonia program. The Ketonia team therefore began its training and programs for correcting the patient's lifestyle (nutrition, sleep, exercise, mental health, and medical care) right away.

In addition, the following goals were set for her:

  1. Improving insulin resistance
  2. Increasing energy and morale
  3. Improving the burning and pain in her feet
  4. Controlling and lowering blood sugar while correcting and reducing her diabetes medication
  5. Correcting food intake and sleep status
  6. Setting a diet suitable for her celiac condition, diabetes, and lipid profile

In the blood test of 04-10-1401 (December 2022), the patient's

After about 25 weeks of treatment and the Ketonia team's lifestyle training, in the blood test of 27-03-1402 (March 2023)

were recorded for the patient, indicating significant changes in her laboratory and anthropometric indicators.

The patient's current medications:

Diabetes is the most common endocrine disease: more than 150 million people worldwide and close to 3 million people in Iran are affected, and a considerable number of cases remain undiagnosed. Based on available data, the prevalence of diabetes is estimated to reach 300 million by 2025. Considering the mortality and disability caused by its chronic complications and its enormous economic burden, this disease is a major health problem. As in other developing countries, the prevalence of diabetes in Iran is rising. Lifestyle and nutrition correction therefore appears to be the best and least costly way to prevent and treat diabetes. That is why the Ketonia team aims, through lifestyle and nutrition education tailored to each person's way of life, to take an important step in helping patients with diabetes and metabolic syndrome.

Chart 2: BMI changes
Chart 3: Waist circumference changes
Chart 4: Hip circumference changes
Figure 1: Blood test, 04-10-1401 (December 2022)
Figure 2: Blood test, 27-03-1402 (March 2023)
Chart 5: Fasting glucose changes
Chart 6: 2-hour glucose changes